Clinical trials
Observational trials in Latvia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 8 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 11 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 56 |
| Recruiting | 17 |
| Unknown status | 9 |
| Active, not recruiting | 6 |
| Enrolling by invitation | 4 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biotronik SE & Co. KG | 7 |
| University of Latvia | 6 |
| AstraZeneca | 5 |
| Biotronik AG | 5 |
| Pauls Stradins Clinical University Hospital | 5 |
| Boehringer Ingelheim | 4 |
| Riga Stradins University | 4 |
| Bayer | 3 |
| Ipsen | 3 |
| Boston Scientific Corporation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 10 |
| Heart Failure | 8 |
| Stomach Neoplasms | 7 |
| Atherosclerosis | 4 |
| Atrial Fibrillation | 4 |
| Diabetes Mellitus | 4 |
| Gastritis, Atrophic | 4 |
| Colorectal Neoplasms | 3 |
| Obesity | 3 |
| Peripheral Arterial Disease | 3 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.